rs857725

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003126.4(SPTA1):​c.5077A>C​(p.Lys1693Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 1,613,752 control chromosomes in the GnomAD database, including 59,409 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4874 hom., cov: 32)
Exomes 𝑓: 0.27 ( 54535 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0140

Publications

47 publications found
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]
SPTA1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • elliptocytosis 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • pyropoikilocytosis, hereditary
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.7916174E-4).
BP6
Variant 1-158638145-T-G is Benign according to our data. Variant chr1-158638145-T-G is described in ClinVar as Benign. ClinVar VariationId is 258943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.437 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003126.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTA1
NM_003126.4
MANE Select
c.5077A>Cp.Lys1693Gln
missense
Exon 36 of 52NP_003117.2P02549-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTA1
ENST00000643759.2
MANE Select
c.5077A>Cp.Lys1693Gln
missense
Exon 36 of 52ENSP00000495214.1P02549-1

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36294
AN:
152018
Hom.:
4864
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.325
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.452
Gnomad SAS
AF:
0.185
Gnomad FIN
AF:
0.329
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.265
Gnomad OTH
AF:
0.259
GnomAD2 exomes
AF:
0.280
AC:
69723
AN:
249014
AF XY:
0.275
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.363
Gnomad ASJ exome
AF:
0.237
Gnomad EAS exome
AF:
0.434
Gnomad FIN exome
AF:
0.344
Gnomad NFE exome
AF:
0.271
Gnomad OTH exome
AF:
0.285
GnomAD4 exome
AF:
0.268
AC:
391943
AN:
1461616
Hom.:
54535
Cov.:
42
AF XY:
0.265
AC XY:
192648
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.119
AC:
3978
AN:
33472
American (AMR)
AF:
0.359
AC:
16023
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.235
AC:
6135
AN:
26130
East Asian (EAS)
AF:
0.408
AC:
16198
AN:
39692
South Asian (SAS)
AF:
0.182
AC:
15705
AN:
86258
European-Finnish (FIN)
AF:
0.340
AC:
18161
AN:
53350
Middle Eastern (MID)
AF:
0.280
AC:
1615
AN:
5766
European-Non Finnish (NFE)
AF:
0.268
AC:
297441
AN:
1111894
Other (OTH)
AF:
0.276
AC:
16687
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
18516
37032
55547
74063
92579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9938
19876
29814
39752
49690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36344
AN:
152136
Hom.:
4874
Cov.:
32
AF XY:
0.243
AC XY:
18101
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.121
AC:
5038
AN:
41522
American (AMR)
AF:
0.316
AC:
4833
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
819
AN:
3472
East Asian (EAS)
AF:
0.452
AC:
2329
AN:
5154
South Asian (SAS)
AF:
0.186
AC:
896
AN:
4820
European-Finnish (FIN)
AF:
0.329
AC:
3488
AN:
10588
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.265
AC:
18012
AN:
67986
Other (OTH)
AF:
0.261
AC:
551
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1375
2750
4124
5499
6874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
19196
Bravo
AF:
0.238
TwinsUK
AF:
0.268
AC:
995
ALSPAC
AF:
0.260
AC:
1002
ESP6500AA
AF:
0.123
AC:
467
ESP6500EA
AF:
0.262
AC:
2159
ExAC
AF:
0.273
AC:
33025
Asia WGS
AF:
0.347
AC:
1202
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
1
Elliptocytosis 2 (1)
-
-
1
Hereditary spherocytosis type 3 (1)
-
-
1
Pyropoikilocytosis, hereditary (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.034
DANN
Benign
0.50
DEOGEN2
Benign
0.17
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.00048
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
PhyloP100
-0.014
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.74
N
REVEL
Benign
0.013
Sift
Benign
0.26
T
Sift4G
Uncertain
0.048
D
Polyphen
0.0
B
Vest4
0.053
MPC
0.029
ClinPred
0.0070
T
GERP RS
-5.4
Varity_R
0.28
gMVP
0.061
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs857725; hg19: chr1-158607935; COSMIC: COSV63750569; COSMIC: COSV63750569; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.